Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion F Gruber

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|February 23, 2023
Approaches to demonstrating the effectiveness of filovirus vaccines: Lessons from Ebola and COVID-19Marion F Gruber, Steven Rubin, Philip R Krause
The Lancet. Infectious Diseases|May 27, 2015
Approaches to demonstration of Ebola virus vaccine efficacyPhilip R Krause, Marco Cavaleri, Gina Coleman, et al.
The Journal of Infectious Diseases|March 15, 2014
Clinical evaluation of pertussis vaccines: US Food and Drug Administration regulatory considerationsKaren M Farizo, Drusilla L Burns, Theresa M Finn, et al.
Science Translational Medicine|May 8, 2015
Immunology of protection from Ebola virus infectionPhilip R Krause, Paula R Bryant, Thomas Clark, et al.
The Journal of Infectious Diseases|December 22, 2017
Clinical Development Strategies and Considerations for Zika Vaccine LicensureMarion F Gruber, Karen M Farizo, R Douglas Pratt, et al.
Biologicals : Journal of the International Association of Biological Standardization|November 17, 2023
Enabling the evaluation of COVID-19 vaccines with correlates of protectionArnaud Marchant, Pierre Van Damme, Stanley Plotkin, et al.
Biologicals : Journal of the International Association of Biological Standardization|July 15, 2020
Report of the second international conference on next generation sequencing for adventitious virus detection in biologics for humans and animalsArifa S Khan, Johannes Blümel, Dieter Deforce, et al.
Vaccine|August 8, 2022
Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluationPhilip R Krause, Narendra Arora, William Dowling, et al.
NPJ Vaccines|April 29, 2024
Realising the potential of correlates of protection for vaccine development, licensure and use: short summaryDeborah F King, Helen Groves, Charlie Weller, et al.
Vaccine|January 24, 2026
Report of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccinesWilliam P Hausdorff, Marco Cavaleri, Marion F Gruber, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|February 23, 2023
Approaches to demonstrating the effectiveness of filovirus vaccines: Lessons from Ebola and COVID-19Marion F Gruber, Steven Rubin, Philip R Krause
The Lancet. Infectious Diseases|May 27, 2015
Approaches to demonstration of Ebola virus vaccine efficacyPhilip R Krause, Marco Cavaleri, Gina Coleman, et al.
The Journal of Infectious Diseases|March 15, 2014
Clinical evaluation of pertussis vaccines: US Food and Drug Administration regulatory considerationsKaren M Farizo, Drusilla L Burns, Theresa M Finn, et al.
Science Translational Medicine|May 8, 2015
Immunology of protection from Ebola virus infectionPhilip R Krause, Paula R Bryant, Thomas Clark, et al.
The Journal of Infectious Diseases|December 22, 2017
Clinical Development Strategies and Considerations for Zika Vaccine LicensureMarion F Gruber, Karen M Farizo, R Douglas Pratt, et al.
Biologicals : Journal of the International Association of Biological Standardization|November 17, 2023
Enabling the evaluation of COVID-19 vaccines with correlates of protectionArnaud Marchant, Pierre Van Damme, Stanley Plotkin, et al.
Biologicals : Journal of the International Association of Biological Standardization|July 15, 2020
Report of the second international conference on next generation sequencing for adventitious virus detection in biologics for humans and animalsArifa S Khan, Johannes Blümel, Dieter Deforce, et al.
Vaccine|August 8, 2022
Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluationPhilip R Krause, Narendra Arora, William Dowling, et al.
NPJ Vaccines|April 29, 2024
Realising the potential of correlates of protection for vaccine development, licensure and use: short summaryDeborah F King, Helen Groves, Charlie Weller, et al.
Vaccine|January 24, 2026
Report of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccinesWilliam P Hausdorff, Marco Cavaleri, Marion F Gruber, et al.
Pageof 3